Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Paclitaxel (Primary) ; Pazopanib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Nov 2016 Status changed from active, no longer recruiting to completed, according to results published in the British Journal of Dermatology.
- 01 Nov 2016 Results of this exploratory study, published in the British Journal of Dermatology.